Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser photocoagulation plus anti-VEGF versus anti-VEGF alone for diabetic macular edema
NL-OMON25771Suspended
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Jan 2013
- Countries
- 1
01
Overview
Randomised, double-blind trial in diabetic macular edema (DME) (3 arms), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Proportion of treatment failures at 72 weeks. Started Jan 2013; status: suspended.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NL-OMON25771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25771.